The Smallest Dose of Wegovy and Why It Exists

You're starting at 0.25mg, here's what that actually means

Imagine you've just received your first Wegovy pen. The dose dial is set at 0.25mg, and you're wondering whether that small number will do anything at all. The honest answer is: not much, weight-wise, in those first four weeks. That's completely by design.

Semaglutide is a GLP-1 receptor agonist, it mimics a gut hormone that slows gastric emptying and damps down appetite. At full therapeutic doses those effects are significant. Introduce them too fast and the most likely result is a week of nausea, sometimes worse. The 0.25mg semaglutide smallest dose sidesteps most of that by giving your gut time to adapt before the medicine starts working in earnest.

The licensed schedule runs 0.25mg for four weeks, then 0.5mg, then 1mg, then 1.7mg, before arriving at the 2.4mg maintenance dose, a process that takes roughly sixteen to twenty weeks in total. The newer 7.2mg option follows the same escalation pathway; your prescriber would guide that separately. If you want to understand how the full schedule unfolds, the Wegovy doses overview covers each step in detail. The key point at 0.25mg is that you are not behind. You are exactly where you should be.

Why the smallest dose sets the pattern for everything that follows

One thing our prescribers hear fairly often is frustration that progress feels slow in the first month. It's understandable, people start Wegovy with a clear goal in mind and the starter dose can feel like a formality. But the first four weeks matter more than they look.

Your body is learning how to handle semaglutide. Appetite changes at 0.25mg are usually subtle; some people notice them, others barely do. What the low dose does reliably is reveal whether you have a particular sensitivity to GI effects (nausea, loose stools, reflux, burping) so that your prescriber can, if necessary, slow the titration rather than push through discomfort. That information shapes the rest of your treatment.

There is also the question of injection technique. Getting comfortable with the pen at a low dose, before the doses that do more heavy lifting, is genuinely useful. A guide to what each Wegovy pen and dose format involves can help you feel confident before your first injection.

Clinical trial data supports the graduated approach: in the STEP 1 trial, published in the New England Journal of Medicine, participants who reached the 2.4mg maintenance dose achieved an average weight reduction of around 15% over 68 weeks, a result that depends on people staying in treatment long enough for the dose to build. Tolerability in the early weeks is part of how that happens. You can read the STEP 1 trial in the New England Journal of Medicine for the full methodology.

Side effects at the smallest Wegovy dose, and what to watch for

Even at 0.25mg, some people experience the GI effects associated with semaglutide. Nausea is the most common. Constipation, indigestion and a general feeling of fullness at smaller meals are also reported. Most of these are mild and settle as the body adjusts, they are typically at their worst in the days after each injection and ease toward the end of the week.

A small number of people experience symptoms that need attention regardless of dose. The MHRA has highlighted acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines: severe, persistent stomach pain that spreads to the back, with or without vomiting, should prompt urgent medical advice rather than a wait-and-see approach. Yellow Card reporting is available at yellowcard.mhra.gov.uk for anyone who wants to report a suspected reaction.

For most people at 0.25mg, the experience is milder than they expected. Staying well hydrated, eating smaller portions rather than trying to clear a full plate, and keeping protein intake up are practical steps that help. Specific dietary guidance should come from your prescriber or a dietitian, not this page.

What happens after 0.25mg, and how to think about the bigger picture

The smallest dose of Wegovy is a starting point, not a destination. If you are preparing to administer your injection for the first time, our guidance on what to expect from your first dose of Wegovy walks through the practicalities before you begin. After four weeks, a prescriber reviews progress, and the typical next step is 0.5mg. Understanding how each Wegovy dose works and when it changes can help you follow the schedule with confidence rather than uncertainty. The schedule continues upward until you reach a dose that produces meaningful results with manageable side effects. For most people in the licensed trials that was 2.4mg, though many patients ask whether 2.4mg is the highest dose of Wegovy available, particularly since the MHRA approved a 7.2mg option for some patients, and our page on what the highest dose of Wegovy involves explains the clinical criteria and what to expect if your prescriber considers it for you.

What this journey costs in private practice is a reasonable question at this point. Pricing varies by dose and provider; the treatment overview sets out what is included in a private prescription through a regulated pharmacy service, including consultation, clinical review and delivery.

Wegovy is a prescription-only medicine. Every step of the schedule (how fast you move up, whether you hold at a dose, whether you're a candidate for 7.2mg) is a clinical decision made by a prescriber who has reviewed your full picture. The NHS England guidance on weight-management injections outlines the clinical framework these decisions sit within.

If you'd like a prescriber to look at where you are in your treatment, or whether Wegovy is the right starting point for you at all, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not a triage algorithm.